交易中 12-17 10:39:23 美东时间
+0.025
+0.30%
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
12-16 09:36
Keefe, Bruyette & Woods analyst Jade Rahmani downgrades Arbor Realty Trust (NYSE:ABR) from Market Perform to Underperform and lowers the price target from $11 to $8.5.
12-15 20:38
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
JP Morgan analyst Richard Shane maintains Arbor Realty Trust (NYSE:ABR) with a Underweight and lowers the price target from $10 to $9.
12-05 01:42
加密概念反弹!Robinhood大涨11%,公司大举押注预测市场,看涨期权占近70%,成交环比放量1.6倍;甲骨文股价重返200美元,却获PUT单看跌至150美元>>
11-28 18:52
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
Arbor Realty Trust shares are trading lower after the company reported mixed Q3...
10-31 23:54
Arbor Realty Trust (NYSE:ABR) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.23 by 48.94 percent. This is a 18.6 percent decrease over earnings of $0.43 per share from the
10-31 20:32
Companies Reporting Before The Bell • T. Rowe Price Group (NASDAQ:TROW) is esti...
10-31 19:11
Arbor Realty Trust (NYSE:ABR) is preparing to release its quarterly earnings on...
10-31 00:01